# How We Review Evidence

Canonical: https://supplementexplained.com/how-we-review-evidence/
Last modified: 2026-05-16T21:40:28+00:00
Indexing: noindex, follow. This markdown file is a machine-readable alternate of the canonical HTML page.
Publisher: Supplement Explained
Review model: Editorial evidence review, not medical review unless explicitly stated on the canonical page.

How We Review Evidence Supplement topics often sit in a messy middle: some have stronger evidence for narrow use cases, some have mixed evidence, and some are marketed much more confidently than the research supports. Our job is to translate that honestly. We want a reader to understand not only what a supplement has been studied for, but also how strong the evidence looks, what the research leaves out, and what practical factors change the real-world fit. What we weigh most Source strength before excitement This page explains why broad government guidance, higher-quality reviews, and careful uncertainty framing usually matter more than a single exciting supplement study. Workflow Research Process See how page framing and source review happen before publishing. Rules Editorial Policy See the publishing standard evidence has to support. Applications Quality Pages See where label claims and testing language get translated for readers. Narrower pages Products See how ingredient evidence differs from product fit analysis. How a page is framed before research starts We try to define the real user decision first. Sometimes the page should answer an ingredient question. Sometimes it should answer a timing question, a safety question, a lab question, or a product-comparison question. That framing matters because supplement content becomes less useful when it gives a broad benefits list to someone whose real problem is medicine spacing, ferritin, or formula quality. How we describe evidence strength Instead of pretending every topic has a clean yes-or-no answer, we use plainer evidence language such as stronger evidence, moderate evidence, mixed evidence, limited evidence, or mostly anecdotal concern. That keeps the page more useful for real decisions than exaggerated certainty would. Evidence grade system We now separate evidence into practical grades before a page turns research into a decision. The highest-confidence language is reserved for human outcome evidence, especially systematic reviews, meta-analyses, and randomized controlled trials that match the use case, dose, and population being discussed. Grade A - stronger human evidence: systematic reviews, meta-analyses, or multiple relevant randomized trials with practical outcomes. Grade B - useful but narrower human evidence: randomized or controlled human studies that are promising but limited by dose, population, duration, or outcome choice. Grade C - mixed or indirect evidence: human evidence exists, but results conflict or the product label does not cleanly match what was studied. Grade D - early evidence: mechanism, animal, in vitro, biomarker, or very small human evidence that should not be treated like a proven outcome. Grade E - marketing or anecdote only: brand claims, user reports, or social media patterns that may explain interest but do not prove benefit. Supplement Explained Score The Supplement Explained Score is our product-page decision score. It is not a doctor approval badge, star rating, lab certificate, or promise that a product will work. It is a structured way to show how much a product page can support a buying decision from visible label, evidence, safety, testing, and value signals. Product pages are scored across five axes: label clarity, evidence transfer, safety fit, quality proof, and value fit. The score is meant to reward pages and products where the decision is easier to verify, and to penalize uncertainty when a label relies on vague claims, thin testing language, unclear dosing, or a weak match between research and the actual formula. How we use anecdotal reports Public discussions can help surface recurring confusion, tolerance problems, product-friction themes, and user-language that readers actually use. They are valuable for context, not proof. When we summarize recurring themes from public discussions, we label them as anecdotal and place them below the main evidence or formula analysis instead of using them to drive the whole page. When safety and lab context outrank upside Some supplement questions cannot be answered responsibly by focusing on benefits first. Iron, vitamin D, biotin, magnesium, electrolytes, sleep aids, and blood-sugar-support supplements can all involve medicine interactions, lab interpretation, high-dose overlap, or referral points that matter more than the marketing promise. In those cases, safety or lab context becomes part of the main answer. How product evidence differs from ingredient evidence Ingredient owner pages cover the broad topic. Product pages ask a narrower question: what does this exact label deliver, what quality signals exist, what tradeoffs stand out, and how does this product compare with nearby alternatives? A product page should never hide behind broad ingredient evidence if the product's actual formula, dose, format, or cost changes the decision in a meaningful way. What types of evidence matter most for supplement claims? Human data usually matters most when the question is whether a supplement may help real people in a real use case. Mechanism, animal, and lab data can still matter, but they do not automatically carry the same weight as better human evidence. How do we handle conflicting study results? We do not force a clean answer when the evidence stays mixed. If trials disagree, we try to explain what keeps changing across study design, dose, population, and outcome rather than cherry-pick the paper that sounds the most exciting. Why does study dosage matter when reviewing evidence? Because a supplement can be studied at one amount and sold at another. If the label dose does not line up well with what has actually been studied, the shopper needs to know that before assuming the evidence transfers cleanly to the product. Key Takeaways Evidence is translated into decisions, not inflated into certainty. The Supplement Explained Score rates decision support, not medical approval or guaranteed product quality. Government and institutional sources help anchor broad facts and safety. Anecdotal reports are used for context only and labeled clearly. Some supplement pages should prioritize safety, labs, and referral points over upside. Next Questions to Read Research Process Editorial Policy Medical Review Policy Supplement Explained Score When to Talk to a Clinician How to Read a Supplement Label About Source Priority Government and institutional sources first. NIH ODS, NCCIH, MedlinePlus, FDA, FTC, and similar sources help anchor broad facts, safety, and regulatory context. Reviews before hype. Systematic reviews and meta-analyses usually matter more than a single exciting trial. Stronger trials over thin claims. When use-case detail matters, randomized trials and stronger reviews help clarify what was actually studied. Anecdotes stay in their lane. Public discussions can show friction and recurring complaints, but they do not replace evidence.